Modern Synthesis
London
About Modern Synthesis
Modern Synthesis is a biotech company bringing life to new materials. Founded by ex-Adidas designer Jen Keane and synthetic biologist Dr. Ben Reeve, the company uses material science to transform nanocellulose - a natural by-product of fermentation - into a new class of responsible textiles and coatings. Designed for application in the fashion industry and beyond, which offer: (1) Performance without plastics or harsh chemicals: Materials which achieve strength and durability without petrochemical binders, harmful chemistries or toxic by-products. (2) Aesthetics without animals: A versatile process that unlocks a wide range of looks, feels, and functions to meet designers’ seasonal needs with zero animal inputs. (3) Scale without starting from scratch: A process that leverages abundant raw materials and is designed to integrate with existing manufacturing infrastructure. Modern Synthesis’ technology leverages the intrinsic versatility of bacterial nanocellulose, which is nature’s finest and strongest form of cellulose. Their process not only displaces animal leathers, plastic-based synthetics and other nonwoven textiles, but also generate entirely new possibilities for designers. For more information, visit modernsynthesis.com.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $9.6M
- Funding stage: Seed
- Last round: Seed (Feb 2025)
- Website: modern-synthesis.com
- Phone: [email protected]
Industries & Categories
Advanced Materials, Apparel, Biotechnology, Fashion, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/modern-synthesis-108001 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.